Breaking News

HealthTech for Treatment: Programs are now open up for European innovative healthcare businesses for the 4th edition of the HealthTech Innovation Times (13th & 14th, Oct 2022) | Taiwan Information

HealthTech for Treatment: Programs are now open up for European innovative healthcare businesses for the 4th edition of the HealthTech Innovation Times (13th & 14th, Oct 2022) | Taiwan Information

PARIS, FRANCE – EQS Newswire – 4 Could 2022 – The HealthTech Innovation Days (HTID®) function, held by the HealthTech For Treatment endowment fund, will get area on 13th and 14th October 2022 and will present a discussion board for promising European lifestyle sciences corporations to accelerate their development and convey their methods to individuals additional quickly. The 4th version will take place in a hybrid structure, in Paris, in the HealthTech room, and in digital method.

The celebration provides the system and the opportunity of just one-on-a person conferences amongst firms, investors and industrial and pharmaceutical organizations, as nicely as thematic panels led by worldwide belief leaders.

Businesses fascinated in collaborating in HTID® are invited to utilize. A jury will satisfy every single fortnight to evaluation the programs. The range requirements are as follows:

  • Biotechs that are producing a procedure at this time in clinical section
  • Medtechs that are creating a technology close to or on the industry
  • Impressive provider firms acquiring ground breaking solutions and products and services in high demand from customers by health care gamers
  • Electronic Wellbeing giving a merchandise made or under advancement with associates this sort of as hospitals, pharmas or industrial companies.

Registration hyperlink:

For the 4th consecutive year, we are happy to co-organise the new version of the HealthTech Innovation Times, a European function which is now a must-show up at event for the overall health care innovation ecosystem. The collaborating corporations are essential players in this sector to satisfy the challenges of tomorrow and our ambition is to assistance them and accelerate their enhancement, hence aiding patients to have more rapidly entry to the most up-to-date improvements“, Maryvonne Hiance, President of the HealthTech For Treatment endowment fund.

The 4th version of the HTID® is supported by its extended-term partners: Amgen Innovation, Icosa, Commit Securities, Servier and Sofinnova Partners.

Final Oct, the 2021 version of HTID® was a good results with additional than 800 registered contributors, 155 revolutionary European healthcare corporations (biotech, medtech, e-health and fitness), 300 worldwide traders, 1.300 private meetings and conferences highlighting main current issues in everyday living sciences with global professionals from the ecosystem.

About HealthTech For Treatment

The HealthTech For Care Endowment Fund is intended to help and market obtain to health care for all and, additional precisely, to new healthcare technologies and medicines. The missions of the endowment fund are organised all-around three major places: to support the advancement of the full health care ecosystem, to accelerate the growth of ground breaking therapies and medications, and to advertise improved accessibility for sufferers to the health care system in France and Europe. The governance of HealthTech For Treatment contains Maryvonne Hiance, Elsy Boglioli, David Caumartin, Pierre Courteille, Eric Falcand, Frédéric Girard, Marc Julien, Cédric Moreau, Christian Pierret and Christian Policard.

HealthTech For Treatment is supported by its founder France Biotech and the network of French health clusters: Atlanpole biotherapies, BioValley France, EuroBioMed, LyonBioPole, Medicen and the NSL clubster. The endowment fund is also supported by lots of European gamers: Asebio, BioAlps, Bio Deutschland, BioWin, CEBR, EIT Health, Federchimica Assobiotec,, Flanders.HealthTech, HollandBio, Irefi, and SwissBiotech and French: BusinessFrance.


The issuer is exclusively responsible for the articles of this announcement.